Statistics
Publications
2
Citations
33
H-Index
2
Active since
2018
Affiliations
Michael Lauw is an author at Heron Therapeutics (United States) specializing in chemotherapy, chemotherapy drug administration, and acute chemotherapy-induced nausea.
Publications per year
2018–2018
2
2
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects
Tom Ottoboni, Michael Lauw, Mary Rose Keller et al. · Future Oncology · 2018 · 22 citations · Full text
HTX-019 via 2-Min Injection or 30-Min Infusion in Healthy Subjects
Thomas Ottoboni, Michael Lauw, Mary Rose Keller et al. · Future Oncology · 2018 · 11 citations · Full text
1–2 of 2